Tsunokawa Yoshiki, Tsukada Mana, Inoue Tatsuki, Tamaoka Masashi, Mugita Toshiki, Chuluunbat Oyunchimeg, Maeda Yoshiko, Fukagai Takashi, Ogawa Yoshio, Sunagawa Masataka
Department of Physiology, Showa University Graduate School of Medicine, Tokyo, JPN.
Department of Urology, Showa University School of Medicine, Tokyo, JPN.
Cureus. 2024 Jan 14;16(1):e52238. doi: 10.7759/cureus.52238. eCollection 2024 Jan.
Yokukansan (YKS), a Kampo formula used in traditional Japanese medicine, has an analgesic effect, and is used for various pain disorders. This study investigated its analgesic effects on Hunner-type interstitial cystitis (HIC) and its mechanism of action in animal models. Methods: Rats with toll-like receptor-7 agonist (loxoribine)-induced HIC were used. Eight-week-old female Wistar rats were divided into three groups: control, HIC, and HIC-administered YKS (YKS + HIC). Bladder pain was assessed based on escape behavior using the von Frey test. Three days after HIC induction, the bladder and spinal cord were excised, and the expression of substance P (SP) was examined. Results: The pain threshold decreased significantly in the HIC group compared to that in the control group, but this decrease was suppressed by further YKS administration. The expression of SP in the bladder wall and spinal cord increased significantly in the HIC group compared to that in the control group; however, this increase was suppressed by YKS administration.
SP is involved in the onset of bladder pain via neurokinin 1 receptors in bladder tissue. YKS may be useful for managing HIC-induced pain, and the suppression of SP secretion is one of its mechanisms of action.
yokukansan(YKS)是一种用于传统日本医学的汉方制剂,具有镇痛作用,可用于治疗各种疼痛性疾病。本研究调查了其对Hunner型间质性膀胱炎(HIC)的镇痛作用及其在动物模型中的作用机制。
使用 toll样受体-7激动剂(洛索立宾)诱导的HIC大鼠。将8周龄雌性Wistar大鼠分为三组:对照组、HIC组和给予YKS的HIC组(YKS + HIC)。使用von Frey试验基于逃避行为评估膀胱疼痛。在诱导HIC三天后,切除膀胱和脊髓,并检测P物质(SP)的表达。
与对照组相比,HIC组的疼痛阈值显著降低,但进一步给予YKS可抑制这种降低。与对照组相比,HIC组膀胱壁和脊髓中SP的表达显著增加;然而,给予YKS可抑制这种增加。
SP通过膀胱组织中的神经激肽1受体参与膀胱疼痛的发生。YKS可能对治疗HIC引起的疼痛有用,抑制SP分泌是其作用机制之一。